We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Designing “Living Medicines” To Target Tumors Precisely

News   Nov 27, 2020 | Original story from UC San Francisco

 
Designing “Living Medicines” To Target Tumors Precisely
 
 
Advertisement
 

RELATED ARTICLES

Using Improved Patient-Derived Tumor Models To Personalize Cancer Care

News

Researchers suggest a major hurdle to identifying new efficacious drugs is the paucity of models for cancer research that accurately represent patient tumors. They now provide a perspective on strategies for developing better models to help personalize cancer care.

READ MORE

Key to Improving Honey Bee Pathogen Tolerance May Lay With Wild Relatives

News

Understanding the genetic and environmental factors that enable some feral honey bee colonies to tolerate pathogens and survive the winter in the absence of beekeeping management may help lead to breeding stocks that would enhance survival of managed colonies, according to a recent study.

READ MORE

Infant Immune Cells Not Functionally Immature as Previously Thought

News

A study has shown that putatively immature dendritic cells found in young children are able to induce robust immune responses. The results could lead to improved vaccination protocols.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE